NO20000324L - Benzotia (oksa) diazolderivater og deres anvendelse som endotelinreseptorantagonister - Google Patents
Benzotia (oksa) diazolderivater og deres anvendelse som endotelinreseptorantagonisterInfo
- Publication number
- NO20000324L NO20000324L NO20000324A NO20000324A NO20000324L NO 20000324 L NO20000324 L NO 20000324L NO 20000324 A NO20000324 A NO 20000324A NO 20000324 A NO20000324 A NO 20000324A NO 20000324 L NO20000324 L NO 20000324L
- Authority
- NO
- Norway
- Prior art keywords
- endothelin receptor
- benzotia
- oxa
- receptor antagonists
- diazole derivatives
- Prior art date
Links
- 229940118365 Endothelin receptor antagonist Drugs 0.000 title 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical class C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 title 1
- 239000002308 endothelin receptor antagonist Substances 0.000 title 1
- 102000010180 Endothelin receptor Human genes 0.000 abstract 1
- 108050001739 Endothelin receptor Proteins 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19731571A DE19731571A1 (de) | 1997-07-23 | 1997-07-23 | Endothelin-Rezeptor-Antagonisten |
| PCT/EP1998/003957 WO1999005132A1 (de) | 1997-07-23 | 1998-06-29 | Benzothia(oxa)diazolderivate und ihre verwendung als endothelin-rezeptor-antagonisten |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20000324D0 NO20000324D0 (no) | 2000-01-21 |
| NO20000324L true NO20000324L (no) | 2000-01-21 |
Family
ID=7836588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20000324A NO20000324L (no) | 1997-07-23 | 2000-01-21 | Benzotia (oksa) diazolderivater og deres anvendelse som endotelinreseptorantagonister |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6197800B1 (id) |
| EP (1) | EP1000044A1 (id) |
| JP (1) | JP2001510836A (id) |
| KR (1) | KR20010022004A (id) |
| CN (1) | CN1265102A (id) |
| AR (1) | AR010933A1 (id) |
| AU (1) | AU733338B2 (id) |
| BR (1) | BR9811537A (id) |
| CA (1) | CA2297315A1 (id) |
| DE (1) | DE19731571A1 (id) |
| HU (1) | HUP0003335A2 (id) |
| ID (1) | ID22978A (id) |
| NO (1) | NO20000324L (id) |
| PL (1) | PL338070A1 (id) |
| SK (1) | SK512000A3 (id) |
| TW (1) | TW461887B (id) |
| WO (1) | WO1999005132A1 (id) |
| ZA (1) | ZA986551B (id) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1130027A1 (de) * | 2000-02-29 | 2001-09-05 | Aventis Pharma Deutschland GmbH | Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben |
| RU2203277C2 (ru) * | 2001-07-04 | 2003-04-27 | Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" | Способ получения 5-хлор-2,1,3-бензотиадиазола |
| DE10155076A1 (de) * | 2001-11-09 | 2003-05-22 | Merck Patent Gmbh | Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK20396A3 (en) * | 1993-08-19 | 1997-03-05 | Warner Lambert Co | Substituted 2(5h)furanone, 2(5h)thiophenone or 2(5h)pyrrolone derivatives and pharmaceutical compositions on their base |
| DE19509950A1 (de) * | 1995-03-18 | 1996-09-19 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
| DE19607096A1 (de) * | 1996-02-24 | 1997-08-28 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
-
1997
- 1997-07-23 DE DE19731571A patent/DE19731571A1/de not_active Withdrawn
-
1998
- 1998-06-29 CN CN98807549A patent/CN1265102A/zh active Pending
- 1998-06-29 US US09/463,311 patent/US6197800B1/en not_active Expired - Fee Related
- 1998-06-29 PL PL98338070A patent/PL338070A1/xx unknown
- 1998-06-29 AU AU88022/98A patent/AU733338B2/en not_active Ceased
- 1998-06-29 KR KR1020007000571A patent/KR20010022004A/ko not_active Withdrawn
- 1998-06-29 WO PCT/EP1998/003957 patent/WO1999005132A1/de not_active Ceased
- 1998-06-29 BR BR9811537-5A patent/BR9811537A/pt not_active IP Right Cessation
- 1998-06-29 JP JP2000504129A patent/JP2001510836A/ja active Pending
- 1998-06-29 SK SK51-2000A patent/SK512000A3/sk unknown
- 1998-06-29 HU HU0003335A patent/HUP0003335A2/hu unknown
- 1998-06-29 EP EP98939552A patent/EP1000044A1/de not_active Withdrawn
- 1998-06-29 CA CA002297315A patent/CA2297315A1/en not_active Abandoned
- 1998-07-20 TW TW087111803A patent/TW461887B/zh active
- 1998-07-22 AR ARP980103582A patent/AR010933A1/es not_active Application Discontinuation
- 1998-07-22 ZA ZA9806551A patent/ZA986551B/xx unknown
-
1999
- 1999-04-22 ID IDW991588A patent/ID22978A/id unknown
-
2000
- 2000-01-21 NO NO20000324A patent/NO20000324L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999005132A1 (de) | 1999-02-04 |
| NO20000324D0 (no) | 2000-01-21 |
| AU8802298A (en) | 1999-02-16 |
| AR010933A1 (es) | 2000-07-12 |
| TW461887B (en) | 2001-11-01 |
| SK512000A3 (en) | 2000-07-11 |
| CN1265102A (zh) | 2000-08-30 |
| DE19731571A1 (de) | 1999-01-28 |
| US6197800B1 (en) | 2001-03-06 |
| PL338070A1 (en) | 2000-09-25 |
| EP1000044A1 (de) | 2000-05-17 |
| KR20010022004A (ko) | 2001-03-15 |
| ZA986551B (en) | 1999-09-20 |
| CA2297315A1 (en) | 1999-02-04 |
| BR9811537A (pt) | 2000-08-29 |
| AU733338B2 (en) | 2001-05-10 |
| JP2001510836A (ja) | 2001-08-07 |
| HUP0003335A2 (hu) | 2001-07-30 |
| ID22978A (id) | 1999-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO965125L (no) | Heterosykliske forbindelser med tachykininreseptor-antagonistaktivitet, deres fremstilling og anvendelse | |
| EP1043324A4 (en) | PURINE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM AS AN ACTIVE INGREDIENT | |
| WO2003050087A3 (en) | Novel herbicides | |
| NO996178L (no) | 4-aminopyrrol(3,2-d)pyrimidiner som neuropeptid y- reseptorantagonister | |
| EP0900795A4 (en) | HETEROCYCLICALLY SUBSTITUTED BENZENE DERIVATIVES AND HERBICIDES | |
| AU2003215753A1 (en) | Imidazopyridine derivatives as kinase inhibitors | |
| NO20050648L (no) | Heterocyklisk substituerte benzoylureaer, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter | |
| AU2804400A (en) | Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists | |
| NO20052493L (no) | Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger. | |
| NO20070555L (no) | Kinazolinonderivater som parp-inhibitorer | |
| NO971471L (no) | Nye karboksamider med fungicid aktivitet | |
| NO20023161L (no) | Substituerte piperidiner, legemidler inneholdende disse forbindelser og fremgangsmåter for fremstilling av dem | |
| NO975975L (no) | Vitronektinreseptor-antagonister, fremstilling samt anvendelse derav | |
| TW333527B (en) | Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them | |
| DE69332259D1 (de) | Kondensierte Thiadiazolderivate, Verfahren zu ihrer Herstellung und deren Verwendung | |
| NO20076680L (no) | Utvalgte CGRP-antagonister, metoder for fremstilling av disse og deres anvendelse som medikamenter | |
| NO20022232L (no) | Imidazolforbindelser for anvendelse som inhibitorer for fosfodiesterase VII | |
| MY117680A (en) | 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)- piperidine derivatives | |
| NO20060702L (no) | Aminokinolinderivater og deres anvendelse som adenosin A3 ligander | |
| NO20012544L (no) | Substituerte benzo[de]isokinolin-1,3-dioner | |
| WO2002000638A8 (en) | Substituted phthalides as anti-convulsive drugs | |
| CA2298461A1 (en) | Heterocyclic substituted 4-benzoyl-pyrazole as herbicides | |
| NO20001934L (no) | 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse | |
| NO20022123L (no) | Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII | |
| NO20000324L (no) | Benzotia (oksa) diazolderivater og deres anvendelse som endotelinreseptorantagonister |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |